New Delhi, 7 March 2025: AstraZeneca Pharma India Ltd on Thursday said it has received permission from India's drug regulator to import and sell sodium zirconium cyclosilicate powder for oral suspension used in treatment of hyperkalaemia -- higher than normal potassium level......
View Details

Related News

• Yamunanagar: Two individuals apprehended with 2,352 narcotic capsules from separate locations (09-03-2025)

---

• UP univ’s chancellor, registrar among 3 held in degree scam (09-03-2025)

---

• ICMR launches patent filing support initiative to boost biomedical innovations (09-03-2025)

---

• Fake medicines of 7 brands recovered, Wrappers and packing machines seized, arrested (08-03-2025)

---

• Delhi HC Uphold's Dismissal Of Woman's Complaint Claiming, Survived 25 Gunshots Using Ayurvedic Medicines; held claims were highly improbable and unsupported by evidence (08-03-2025)

---

• Codeine Cough Syrup worth 50 thousand recovered from two interstate drug smugglers, arrested (08-03-2025)

---

• 6 lakh banned capsules and tablets seized in Fazilka, 2 arrested (08-03-2025)

---

• Ayush Directorate hosts awareness program on Rule 170 (08-03-2025)

---

• More prominent warnings about serious side effects for fluoroquinolone antibiotics: TGA (08-03-2025)

---

• 'Exhaustive order' required for effective implementation of DMR Act: SC (08-03-2025)

---